(“Inmedix”), with its recently FDA-cleared CloudHRV ® System, was named by Fitt/Insider as one of 50 of health and wellness’s ...

We've gone through the betting odds to find the best value on tonight's NHL slate. What best bets are we making in our ...

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...

The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and ...

For patients with nonvalvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use ...

New experiential research highlights that women over 45 may have hopeful outcomes for fertility via IVF and natural ...

Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...

A 2026 informational overview of BackRestore's Regenesis Tri-Therapy System for chronic lower back pain, herniated disc support, and pinched nerve relief - how the company describes its home spinal ...

Gastrointestinal (GI) disorders—including IBS, IBD, GERD, peptic ulcers, and constipation—affect a large portion of the global population and impose significant healthcare burdens. Conventional ...

The vaccine was previously approved in the US to prevent LRTD related to RSV infection in adults 60 years or older and high-risk adults aged 50-59 years but remains contraindicate ...

Using computational modeling, a research team has developed a novel peptide (MLPH) that promotes hair growth without the side ...

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...